본문 바로가기

Prediction of future weight change with dopamine transporter in patients with Parkinson's disease

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
저널
JOURNAL OF NEURAL TRANSMISSION126(6) · pp.723 · 2019
피인용
Web of Science 4Scopus 4
FWCI (Scopus)
0.24
JCR IF
JCR 2018 2.903
ISSN
0300-9564

저자

  1. 박경준제1저자교신저자Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan, 49241, Republic of Korea
  2. Kim, HeeyoungDepartment of Nuclear Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Republic of Korea
  3. Seok, Ju WonDepartment of Nuclear Medicine, Chung-Ang University College of Medicine, Seoul, Republic of Korea
  4. 이명준Department of Neurology and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
  5. Shin, SeunghyeonDepartment of Nuclear Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea
  6. 김근영Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan, 49241, Republic of Korea
  7. 이재민Department of Neurosurgery and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
  8. Seo, YoungdukDepartment of Nuclear Medicine, Busan Seongso Hospital, Busan, Republic of Korea
  9. 김범수Department of Nuclear Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Republic of Korea
  10. Jun, SungminDepartment of Nuclear Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Busan, Republic of Korea
  11. 김인주Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, 179 Gudeok-ro, Seo-gu, Busan, 49241, Republic of Korea

초록

Fluctuating body weight is a commonly reported nonmotor feature in patients with Parkinson's disease (PD). We hypothesised that striatal dopamine transporter (DAT) density at the time of diagnosis might play an important role in weight regulation in patients with PD. DAT density was measured from I-123-FP-CIT single-photon emission computed tomography. Region-of-interest analyses were performed to measure the specific binding of I-123-FP-CIT to DAT, and the putamen-to-caudate nucleus ratio (PCR) was calculated. Body weight was measured at baseline (W0) and at 48months (W48). We classified subjects into three groups: weight loss, stable, and weight gain. In final analyses, 163 patients (106 men, 57 women) were included. PCR significantly differed by group in men, but not in women or across all patients. In men, PCR was slightly negatively associated with the percentage change in weight. No such correlation was found across all patients or in women. In univariate and multivariate logistic regression analyses, low PCR was associated with future weight gain in men with PD but not in women. In conclusion, striatal DAT availability at the time of diagnosis could predict subsequent weight change in men with PD.

키워드

Parkinson's diseaseDopamine plasma membrane transport proteinsNeuroimagingObesityBODY-MASS INDEXDIFFERENTIAL ROLESNONMOTOR FEATURESSEX-DIFFERENCESSTRIATUMPUTAMENGAINASSOCIATIONPROGRESSIONNUCLEUS

식별자

Scopus EID
2-s2.0-85066048257
WoS UID
000469230700003